Rombotis Spiro George 4/A
4/A · Cyclacel Pharmaceuticals, Inc. · Filed Dec 16, 2021
Insider Transaction Report
Form 4/AAmended
Rombotis Spiro George
DirectorPresident & C.E.O.
Transactions
- Award
Stock Option (right to buy)
2021-12-13+190,000→ 190,000 totalExercise: $3.45Exp: 2031-12-13→ Common Stock (190,000 underlying)
Footnotes (3)
- [F1]These securities are exercisable over a three-year period, with 1/36 of the options granted vesting on a monthly basis.
- [F2]These securities were granted as part of the Issuer's annual compensation review to executive officers.
- [F3]This Form 4 is being amended to correct a typographical error in the number of shares of Common Stock underlying the options granted to the reporting person on December 13, 2021. 190,000 shares of Common Stock underlie the granted options.